Ovarian Cancer Research Alliance Unites with Rivkin Center to Enhance Cancer Research Efforts
Ovarian Cancer Research Alliance Joins Forces with the Rivkin Center
In a monumental development in the battle against ovarian cancer, the Ovarian Cancer Research Alliance (OCRA) has announced its upcoming merger with the Rivkin Center for Ovarian Cancer Research. This collaboration, which will officially take effect on April 1, 2025, signals a strategic consolidation aimed at bolstering research and support for patients affected by ovarian cancer.
OCRA, recognized as the largest nonprofit organization dedicated to gynecologic cancers globally, is set to integrate the Rivkin Center's impressive legacy of funding innovative research initiatives. The Rivkin Center, a key player in ovarian cancer research located in Seattle, has consistently provided essential seed-funding grants that have spurred significant scientific breakthroughs since its establishment in 1996.
Audra Moran, President and CEO of OCRA, expressed enthusiasm for this partnership, highlighting the complementary nature of the two organizations.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.